Literature DB >> 17376550

Atrial natriuretic peptide (ANP) suppresses acute atrial electrical remodeling in the canine rapid atrial stimulation model.

Toru Yoshida1, Shinichi Niwano, Hiroe Niwano, Ryuta Imaki, Daisuke Satoh, Yoshio Masaki, Kazumi Nakazato, Kazui Soma, Tohru Izumi.   

Abstract

OBJECTIVES: Atrial electrical remodeling is considered to play an important role in the appearance of atrial fibrillation. The effect of atrial natriuretic peptide (ANP) on atrial electrical remodeling was evaluated in a canine atrial stimulation model.
METHODS: In 15 beagle dogs, electrodes for pacing and recording were fixed on the atrial surface. In 10/15 dogs, rapid atrial stimulation (400 bpm) was performed for 7 h at the right atrial appendage (RAA) and the remaining 5 were used as the sham without rapid pacing. In 5/10 dogs with rapid pacing, human atrial natriuretic peptide (ANP) was infused (1.0 microg/kg/min). The effective refractory period (ERP) and the monophasic action potential duration (MAP) were evaluated at 0, 3, and 7 h after rapid pacing. The expression levels of mRNAs of ion channels or transporters were evaluated from the atrial samples of sham and after a 7 hour pacing.
RESULTS: In the control group with rapid pacing (n=5), the atrial ERP and MAP duration were shortened at all atrial sites, e.g., ERP from 148+/-14 ms to 109+/-8 ms at RAA, P=0.006. In contrast in the ANP group, neither the ERP nor MAP duration showed a significant shortening and the effect of ANP on hemodynamic parameter was relatively small. Expression levels of the mRNA were not significantly different between the control and ANP groups.
CONCLUSIONS: Administration of ANP prevented the shortening of the ERP and MAP duration in the rapid atrial stimulation model. The effect of ANP on atrial electrical remodeling was considered to be due to its direct action on the myocardium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376550     DOI: 10.1016/j.ijcard.2006.12.005

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

1.  Neutral endopeptidase inhibitor suppresses the early phase of atrial electrical remodeling in a canine rapid atrial pacing model.

Authors:  Ryuta Imaki; Shinichi Niwano; Hiroe Niwano; Daisuke Satoh; Toru Yoshida; Yoshihiko Masaki; Tohru Izumi
Journal:  Indian Pacing Electrophysiol J       Date:  2008-04-01

2.  Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway.

Authors:  Fan Bai; Yaozhong Liu; Tao Tu; Biao Li; Yichao Xiao; Yingxu Ma; Fen Qin; Jing Xie; Shenghua Zhou; Qiming Liu
Journal:  Lipids Health Dis       Date:  2019-05-10       Impact factor: 3.876

3.  Atrial natriuretic peptide regulates Ca channel in early developmental cardiomyocytes.

Authors:  Lin Miao; Min Wang; Wen-Xuan Yin; Qi Yuan; Ying-Xiao Chen; Bernd Fleischmann; Jürgen Hescheler; Guangju Ji
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

4.  The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.

Authors:  Jun Zhao; Tiecheng Liu; Enzhao Liu; Guangping Li; Lingshan Qi; Jian Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-03-23       Impact factor: 1.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.